Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-063026
Filing Date
2025-06-26
Accepted
2025-06-26 16:00:23
Documents
3
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2519249d1_6k.htm 6-K 12589
2 EXHIBIT 99.1 tm2519249d1_ex99-1.htm EX-99.1 29651
3 GRAPHIC tm2519249d1_ex99-1img001.jpg GRAPHIC 2756
  Complete submission text file 0001104659-25-063026.txt   47342
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 251080278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)